Indications
Negaron Tablet is used for:
Nausea and vomiting, motion sickness, vertigo, meniere's disease, peripheral vascular diseases, cerebrovascular disorders, vestibular disorders
Adult Dose
Oral
Peripheral vascular disease
Adult: 75 mg bid or tid.
Motion sickness
Adult: 30 mg 2 hr before travel then 15 mg 8 hrly during the journey if necessary.
Cerebrovascular disorders
Adult: 75 mg once daily.
Vertigo and vestibular disorders
Adult: 30 mg tid or 75 mg 1-2 times daily.
Child Dose
Oral
Motion sickness
Child: 5-12 yr 15 mg 2 hr before travel then 7.5 mg 8 hrly during the journey as necessary.
Vertigo and vestibular disorders
Child: 5-12 yr 15 mg tid.
Renal Dose
Administration
Should be taken with food.
Contra Indications
Proven hypersensitivity to the drug. Parkinson's disease. Childn and neonates.
Precautions
Hypotension; pregnancy; lactation; elderly. May impair ability to drive or operate machineries.
Pregnancy-Lactation
Interactions
CNS depressant effect enhanced with alcohol. Action potentiated by domperidone. Increased sedative effect w/ CNS depressants or TCAs.
Side Effects
Side effects of Cinnarizine :
Extrapyramidal symptoms sometimes associated with severe depression. Drowsiness, headache, GI upsets, unsteadiness, headache; rarely skin and hypersensitivity reactions, dry mouth, blurred vision, urinary difficulty or retention, constipation and increased gastric reflux, fatigue. Hypolipidaemic effect.
Mode of Action
Cinnarizine has calcium-channel blocking activity selective for arterial smooth muscle. It also has some antihistamine activity. Cinnarizine acts as a labyrinthine sedative. It also improves microcirculation by reducing ischaemia-induced blood viscosity.
Note
Negaron 25 mg Tablet generic name is Cinnarizine. Negaron 25 mg Tablet is manufactured by G. A. Company Ltd.Negaron is availble in all over Bangladesh.
Mes BD drug index information on Negaron Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.